Harnessing host innate immunity may combat acquired resistance to BRAFi

Ítems similars

• HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors
  per: Sottile, Rosa, et al.
  Publicat: (2015)
• NK cells blur the frontier between innate and acquired immunity
  per: Terrazzano, Giuseppe, et al.
  Publicat: (2013)
• Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma
  per: Krayem, Mohammad, et al.
  Publicat: (2018)
• A promising new therapy may assist efforts to combat ICU-acquired weakness
  per: Bain, Sarah, et al.
  Publicat: (2014)
• The Role of Senescent Cells in Acquired Drug Resistance and Secondary Cancer in BRAFi-Treated Melanoma
  per: Thompson, Elizabeth L., et al.
  Publicat: (2021)